Author:
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1304 | 1004 | 61 |
| Full Text Views | 10 | 3 | 0 |
| PDF Downloads | 4 | 1 | 0 |
Fluorescent Antibody Studies in Human Malaria
III. Development of Antibodies to Plasmodium Falciparum in Semi-immune Patients
William E. Collins
William E. Collins
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Parasite Chemotherapy, Section on Cytology, P.O. Box 190, Chamblee, Georgia
Search for other papers by William E. Collins in
Current site
Google Scholar
PubMed
Search for other papers by William E. Collins in
Current site
Google Scholar
PubMed
Geoffrey M. Jeffery
Geoffrey M. Jeffery
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Parasite Chemotherapy, Section on Cytology, P.O. Box 190, Chamblee, Georgia
Search for other papers by Geoffrey M. Jeffery in
Current site
Google Scholar
PubMed
Search for other papers by Geoffrey M. Jeffery in
Current site
Google Scholar
PubMed
Jimmie C. Skinner
Jimmie C. Skinner
National Institutes of Health, National Institute of Allergy and Infectious Diseases, Laboratory of Parasite Chemotherapy, Section on Cytology, P.O. Box 190, Chamblee, Georgia
Search for other papers by Jimmie C. Skinner in
Current site
Google Scholar
PubMed
Search for other papers by Jimmie C. Skinner in
Current site
Google Scholar
PubMed
Summary
Using the indirect fluorescent antibody (FA) method, the production of antibody to Plasmodium falciparum was demonstrated in eight patients having prior experience with strains of the parasite.
The FA endpoints rose rapidly to levels much higher than had been reported for patients who had had no previous experience with P. falciparum.
In two patients, the FA response was such that it was possible to differentiate between endpoints to the Colombia and Thailand strains of P. falciparum.
Author Notes
Present address: Assistant Chief, Laboratory of Parasite Chemotherapy, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20014.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1304 | 1004 | 61 |
| Full Text Views | 10 | 3 | 0 |
| PDF Downloads | 4 | 1 | 0 |